.
MergerLinks Header Logo

Announced

Completed

Altaris Capital Partners completed the acquisition of 3M's drug delivery business for c. $650m.

Financials

Edit Data
Transaction Value£494m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales1.7x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Friendly

Acquisition

Single Bidder

Private

United States

drug delivery

Private Equity

Majority

Pharmaceuticals

Completed

Synopsis

Edit

Altaris Capital Partners, an investment firm, completed the acquisition of a drug delivery business of 3M, an American multinational conglomerate, for c. $650m. Following the acquisition, Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, launched as an independent company. "We are excited to be partnering with 3M and the Kindeva team in this transaction. We believe Kindeva is well-positioned to build on its successful track record as a leading provider of drug delivery technologies," George Aitken-Davies, Altaris Managing Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US